A passion for outthinking cancer
Our collaborations

Innovation doesn’t happen alone.
Learn more about teaming with Merrimack.

Learn more


View all news
August 16, 2019

Merrimack Pharmaceuticals Reschedules 2019 Annual Meeting of Shareholders for October 17, 2019

Read more
July 25, 2019

Merrimack Declares $20 Million Special Dividend

Read more
May 30, 2019

Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend

Read more
May 10, 2019

Merrimack Reports First Quarter 2019 Financial Results

Read more

Social Media

Follow us on Twitter

October 8, 2018
We are taking a systematic approach to our preclinical development work. Learn more about our pipeline here: http://wwZRfyJQ2f

October 5, 2018
Our pipeline is shaped by understanding cancer pathways, treatments designed with pharmacological properties to mat… http://XYlHtTVLHu